Challenges of Drug Development in Progressive Multiple Sclerosis

Possible treatment targets, outcome measures, and more in progressive multiple sclerosis clinical trials

Read more

In a peer-reviewed International Pharmaceutical Industry article, Tomislav Babic discusses biomarkers, clinical outcome measures, study design, and more for progressive multiple sclerosis.


Vice President, Scientific Solutions, Neuroscience

Want to learn more about Worldwide Clinical Trials?